Technical Analysis for LEXX - Lexaria Bioscience Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 3.54 | 3.21% | 0.11 |
LEXX closed up 3.21 percent on Wednesday, May 8, 2024, on 19 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% | |
| 50 DMA Support | Bullish | 3.21% | |
| Pocket Pivot | Bullish Swing Setup | 3.21% | |
| Inside Day | Range Contraction | 3.21% | |
| Wide Bands | Range Expansion | 3.21% |
| Alert | Time |
|---|---|
| Possible NR7 | about 4 hours ago |
| Rose Above Previous Day's High | about 8 hours ago |
| Down 2 % | about 8 hours ago |
| Down 1% | about 8 hours ago |
| Up 2% | about 8 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/12/2024
Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.
Sector: Consumer Defensive
Industry: Packaged Foods
Keywords: Health Sciences Pharmacy Psychoactive Drugs Drug Delivery Smoking Nutraceutical Nicotine Anxiolytics
Classification
Sector: Consumer Defensive
Industry: Packaged Foods
Keywords: Health Sciences Pharmacy Psychoactive Drugs Drug Delivery Smoking Nutraceutical Nicotine Anxiolytics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.85 |
| 52 Week Low | 0.6489 |
| Average Volume | 538,189 |
| 200-Day Moving Average | 1.80 |
| 50-Day Moving Average | 3.27 |
| 20-Day Moving Average | 2.63 |
| 10-Day Moving Average | 3.01 |
| Average True Range | 0.36 |
| RSI (14) | 61.54 |
| ADX | 23.55 |
| +DI | 33.33 |
| -DI | 15.09 |
| Chandelier Exit (Long, 3 ATRs) | 2.60 |
| Chandelier Exit (Short, 3 ATRs) | 2.93 |
| Upper Bollinger Bands | 3.66 |
| Lower Bollinger Band | 1.59 |
| Percent B (%b) | 0.94 |
| BandWidth | 79.05 |
| MACD Line | 0.11 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.1582 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.87 | ||||
| Resistance 3 (R3) | 3.84 | 3.70 | 3.81 | ||
| Resistance 2 (R2) | 3.70 | 3.62 | 3.71 | 3.80 | |
| Resistance 1 (R1) | 3.62 | 3.56 | 3.66 | 3.65 | 3.78 |
| Pivot Point | 3.48 | 3.48 | 3.50 | 3.49 | 3.48 |
| Support 1 (S1) | 3.40 | 3.40 | 3.44 | 3.43 | 3.30 |
| Support 2 (S2) | 3.26 | 3.34 | 3.28 | 3.28 | |
| Support 3 (S3) | 3.18 | 3.26 | 3.27 | ||
| Support 4 (S4) | 3.21 |
